Sanofi SA (NASDAQ:SNY)

42.02
Delayed Data
As of Aug 16
 +0.37 / +0.89%
Today’s Change
40.00
Today|||52-Week Range
45.62
-3.20%
Year-to-Date
Regeneron Gets FDA Nod for Eylea Injection Prefilled Syringe
Aug 15 / Zacks.com - Paid Partner Content
Alnylam's (ALNY) Q2 Earnings and Revenues Miss Estimates
Aug 07 / Zacks.com - Paid Partner Content
Should Value Investors Consider Sanofi (SNY) Stock Now?
Aug 14 / Zacks.com - Paid Partner Content
Regeneron Pharmaceuticals Reports Marked Improvement in Q2
Aug 06 / MotleyFool.com - Paid Partner Content
J&J's Tuberculosis Drug Gets FDA Nod for Adolescent Patients
Aug 12 / Zacks.com - Paid Partner Content
Regeneron (REGN) Q2 Earnings Top Estimates, Eylea Sales Solid
Aug 06 / Zacks.com - Paid Partner Content
AnaptysBio Prepares for a Potential Gear Shift
Aug 10 / MotleyFool.com - Paid Partner Content
SNY vs. PFE: Which Stock Is the Better Value Option?
Aug 06 / Zacks.com - Paid Partner Content
Inovio (INO) Q2 Earnings & Revenues Fall Shy of Estimates
Aug 09 / Zacks.com - Paid Partner Content
Are Investors Undervaluing Sanofi (SNY) Right Now?
Aug 06 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: AGN, NVO Earnings, EU Nod to SNY & ABBV Drugs for New Patients
Aug 09 / Zacks.com - Paid Partner Content
Sanofi (SNY) Q2 2019 Earnings Call Transcript
Aug 05 / MotleyFool.com - Paid Partner Content
3 Dividend Stocks That Pay You More Than Pepsi Does
Aug 07 / MotleyFool.com - Paid Partner Content